Disease & disorder
GM1 gangliosidosis, GLB1-related, dog
MONDO:1010845
A lysosomal storage disease in dogs due to a mutation in the GLB1 gene. There is a buildup of GM1 gangliosides in tissues due to a lack of the enzyme beta-galactosidase. It is characterised by progressive neuromuscular dysfunction and impaired growth from an early age.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.